2017 dengue vaccine controversy in the Philippines

The Dengvaxia controversy, Dengvaxia issue, or Dengvaxia mess [7] is an ongoing controversy which began late November 2017 after the Philippine Department of Health (DOH) suspended a school-based dengue vaccination program [8] utilizing French drug-based vaccine maker Sanofi Pasteur’s Dengvaxia vaccine (Tagalog pronunciation: [9] Shortly after, the company made a statement that its product poses […]